Trial · NCT01413178
Results by group38
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 38
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Progression-Free Survival (PFS) | Busulfan + Melphalan | 72 | Participants | ||
| Progression-Free Survival (PFS) | Melphalan | 50 | Participants | ||
| Number of Participants With Complete Response (CR) | Busulfan + Melphalan | 12 | Participants | ||
| Number of Participants With Complete Response (CR) | Melphalan | 15 | Participants | ||
| Treatment-Related Mortality (TRM) Between 2 Arms. | Busulfan + Melphalan | 0 | Participants | ||
| Treatment-Related Mortality (TRM) Between 2 Arms. | Melphalan | 0 | Participants | ||
| Number of Participants That Had Grade 3-4 Toxicities. | Busulfan + Melphalan | Grade 3 - Diarrhea | 5 | participants | |
| Number of Participants That Had Grade 3-4 Toxicities. | Melphalan | Grade 3 - Diarrhea | 4 | participants | |
| Number of Participants That Had Grade 3-4 Toxicities. | Busulfan + Melphalan | Grade 3 - Elevated ALT | 3 | participants | |
| Number of Participants That Had Grade 3-4 Toxicities. | Melphalan | Grade 3 - Elevated ALT | 0 | participants | |
| Number of Participants That Had Grade 3-4 Toxicities. | Busulfan + Melphalan | Grade 3 - Elevated Tbili | 2 | participants | |
| Number of Participants That Had Grade 3-4 Toxicities. | Melphalan | Grade 3 - Elevated Tbili | 0 | participants | |
| Number of Participants That Had Grade 3-4 Toxicities. | Busulfan + Melphalan | Grade 3 - Infection | 16 | participants | |
| Number of Participants That Had Grade 3-4 Toxicities. | Melphalan | Grade 3 - Infection | 5 | participants | |
| Number of Participants That Had Grade 3-4 Toxicities. | Busulfan + Melphalan | Grade 3 - Mucositis | 15 | participants | |
| Number of Participants That Had Grade 3-4 Toxicities. | Melphalan | Grade 3 - Mucositis | 0 | participants | |
| Number of Participants That Had Grade 3-4 Toxicities. | Busulfan + Melphalan | Grade 3 - Nausea | 5 | participants | |
| Number of Participants That Had Grade 3-4 Toxicities. | Melphalan | Grade 3 - Nausea | 2 | participants | |
| Number of Participants That Had Grade 3-4 Toxicities. | Busulfan + Melphalan | Grade 3 - Neuropathy | 1 | participants | |
| Number of Participants That Had Grade 3-4 Toxicities. | Melphalan | Grade 3 - Neuropathy | 0 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01413178/results